Circulating Tumor Cells, a marker for research labs and CLIA labs for personalized treatment strategy and follow-up :


Personalized medicine

Benefits to patients treatment decision at early-stage and in advanced cancers.

Cost efficiency

Save time of conventional screening personnel by 5 folds while improving the eyes scoring technique sensitivity & specificity.